Planet Labs PBC stock analysis: 58% revenue growth and positive free cash flow, but 15.86 times revenue keeps the model’s signal at Hold.
stock analysis
-
-
Health Care EquipmentUS Stocks
Intuitive Surgical Sits 33% Below Its Two-Year High – Why a 95/100 Quality Score Still Only Earns a Hold
Intuitive Surgical stock analysis: ISRG earns a 95/100 Quality score and 18.5% revenue growth, but a 46.12 P/E keeps the model at Hold.
-
BiotechnologyFeaturedUS Stocks
Incyte Grows Revenue 37.7% at a 15.46 P/E – Can It Outrun the 2028 Jakafi Patent Cliff?
Incyte stock analysis: INCY grows revenue 37.7% at a 15.46 P/E with a 98/100 Quality score. Why the model rates it a Buy despite the 2028 Jakafi cliff.
-
FeaturedPharmaceuticalsUS Stocks
United Therapeutics Rallies on Its Tyvaso IPF Filing – a 95/100 Quality Score at 19.4 Times Earnings
United Therapeutics stock analysis: UTHR rallies on its Tyvaso IPF filing with a 95/100 Quality score and a 19.40 P/E. Why the model rates it a Buy.
-
Food & BeverageUS Stocks
PepsiCo Sinks to a Two-Year Low on a 16.87 P/E and 4.6% Yield – Yet the Model Stops Short of Buy
PepsiCo stock analysis: PEP hits a two-year low on a 16.87 P/E and 4.6% dividend yield. Why leverage and slow growth keep the model at Hold.
-
Renewable UtilitiesUS Stocks
Fervo Energy Hits a Two-Year Low Days After Its Cape Station Geothermal Plant Reached First Power
Fervo Energy Company stock analysis: FRVO hits its two-year low days after Cape Station’s first power. Liquidity, losses and valuation explained.
-
FeaturedSoftwareUS Stocks
PicPay Parent PicS N.V. Sits at Its Two-Year Low Despite 67% Revenue Growth
PicS N.V. stock analysis: PicPay’s parent grew revenue 67% yet trades at a two-year low. Quality, growth and valuation scores explained.